[Clinical evaluation of myocardial preservation with modified young-GIK cardioplegia in infant under 6 years of age].
Hioki
M
M
Utsunomiya
H
H
Wakabayashi
T
T
Sato
Y
Y
Iedokoro
Y
Y
Shoji
T
T
D002675:Child, Preschool; D002951:Citrates / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006324:Heart Arrest, Induced / Q000379:methods*; D006801:Humans; D007036:Hypothermia, Induced; D007223:Infant; D007328:Insulin / Q000627:therapeutic use; D008278:Magnesium Sulfate / Q000627:therapeutic use; D009388:Neostigmine / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D019357:Potassium Citrate
D002951:Citrates; D007328:Insulin; C042312:Young's cardioplegic solution; C030396:glucose-insulin-potassium cardioplegic solution; D009388:Neostigmine; D008278:Magnesium Sulfate; D019357:Potassium Citrate; D005947:Glucose; D011188:Potassium